Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance

被引:9
|
作者
Babrzadeh, Farbod [1 ]
Varghese, Vici [2 ]
Pacold, Mary
Liu, Tommy F.
Nyren, Pal [3 ]
Schiffer, Celia [4 ]
Fessel, W. Jeffrey [5 ]
Shafer, Robert W.
机构
[1] Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Div Infect Dis, Dept Med, Stanford, CA 94305 USA
[3] KTH, AlbaNova Univ Ctr, Dept Biotechnol, Stockholm, Sweden
[4] Univ Massachusetts, Med Ctr, Dept Biochem, Worcester, MA USA
[5] Kaiser Permanente Med Care Program No Calif, Clin Trials Unit, San Francisco, CA USA
关键词
drug resistance; deep sequencing; minority variants; Sanger sequencing; ATAZANAVIR;
D O I
10.1093/jac/dks409
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To determine whether pan-protease inhibitor (PI)-resistant virus populations are composed predominantly of viruses with resistance to all PIs or of diverse virus populations with resistance to different subsets of PIs. We performed deep sequencing of plasma virus samples from nine patients with high-level genotypic and/or phenotypic resistance to all licensed PIs. The nine virus samples had a median of 12 PI resistance mutations by direct PCR Sanger sequencing. For each of the nine virus samples, deep sequencing showed that each of the individual viruses within a sample contained nearly all of the mutations detected by Sanger sequencing. Indeed, a median of 94.9 of deep sequence reads had each of the PI resistance mutations present as a single chromatographic peak in the Sanger sequence. A median of 5.0 of reads had all but one of the Sanger mutations that were not part of an electrophoretic mixture. The collinearity of PI resistance mutations in the nine virus samples demonstrated that pan-PI-resistant viruses are able to replicate in vivo despite their highly mutated protease enzymes. We hypothesize that the marked collinearity of PI resistance mutations in pan-PI-resistant virus populations results from the unique requirements for multi-PI resistance and the extensive cross-resistance conferred by many of the accessory PI resistance mutations.
引用
收藏
页码:414 / 418
页数:5
相关论文
共 50 条
  • [41] Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance
    Weikl, Thomas R.
    Hemmateenejad, Bahram
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2020, 88 (03) : 476 - 484
  • [42] Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase
    Cane, Patricia A.
    Green, Hannah
    Fearnhill, Esther
    Dunn, David
    AIDS, 2007, 21 (04) : 447 - 455
  • [43] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance
    Das, Debananda
    GLOBAL HEALTH & MEDICINE, 2024, 6 (06): : 357 - 362
  • [44] Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
    Su, Chinh Tran-To
    Koh, Darius Wen-Shuo
    Gan, Samuel Ken-En
    MOLECULES, 2019, 24 (18):
  • [45] Tipranavir resistance associated mutations in protease inhibitor-naive patients with HIV-1 subtype A/E infection
    Sungkanuparph, Somnuek
    Sukasem, Chonlaphat
    Manosuthi, Weerawat
    Wiboonchutikul, Surasak
    Piyavong, Bucha
    Chantratita, Wasun
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (03) : 284 - 286
  • [46] NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations
    Ishima, Rieko
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    JOURNAL OF BIOMOLECULAR NMR, 2019, 73 (6-7) : 365 - 374
  • [47] NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations
    Rieko Ishima
    Nese Kurt Yilmaz
    Celia A. Schiffer
    Journal of Biomolecular NMR, 2019, 73 : 365 - 374
  • [48] In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
    Datir, Rawlings
    Kemp, Steven
    El Bouzidi, Kate
    Mlchocova, Petra
    Goldstein, Richard
    Breuer, Judy
    Towers, Greg J.
    Jolly, Clare
    Quinones-Mateu, Miguel E.
    Dakum, Patrick S.
    Ndembi, Nicaise
    Gupta, Ravindra K.
    MBIO, 2020, 11 (06): : 1 - 15
  • [49] Structure-based phenotyping predicts HIV-1 protease inhibitor resistance
    Shenderovich, MD
    Kagan, RM
    Heseltine, PNR
    Ramnarayan, K
    PROTEIN SCIENCE, 2003, 12 (08) : 1706 - 1718
  • [50] Epistasis among Deleterious Mutations in the HIV-1 Protease
    Parera, Mariona
    Perez-Alvarez, Nuria
    Clotet, Bonaventura
    Angel Martinez, Miguel
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 392 (02) : 243 - 250